Skip to content

Priscilla Chan on AI's potential in rare disease research and personalized medicine

CNBC Television · · 30-second read

Share

Top comments from YouTube.

    November 20, 2026 · Emerging AI

    Philanthropist Priscilla Chan, co-founder of the Chan Zuckerberg Initiative and Biohub, discusses how rare disease research has advanced dramatically over the past decade, moving from genetic mystery to clinical trials. In an interview with CNBC's Becky Quick, Chan draws on her background as a pediatrician to explain how rare disease groups are building research programs, patient registries and clinical trials that could reshape broader disease treatment approaches.

    Chan highlights AI's emerging role in accelerating biomedicine and personalized medicine. She describes how the Chan Zuckerberg Initiative and Biohub, co-founded with her husband Mark Zuckerberg, are funding rare disease pioneers and supporting the infrastructure needed to turn genetic understanding into working therapies.

    Read the full story at CNBC Television

    This is an AI-written summary. The original reporting belongs to CNBC Television. How we write these · Spot a mistake?

    Get the AI brief every morning.

    The five AI stories that matter each morning: startups, money, jobs, tech and what's coming next. Free, and one click to unsubscribe. See our Privacy Policy.